BeOne Medicines Ltd. (ONC) Guidance & Earnings Results
On 2026-08-05 BeOne Medicines Ltd. raised guidance: "FY2026 total revenue raised to $6.6-6.8B; GAAP operating income $1-1.1B; non-GAAP operating income $1.7-1.8B; gross margin high-80% range; other income (expense) $25-50M expense; diluted ADS outstanding…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ONCBeOne Medicines Ltd.Follow ONC — free
—
Price chart with a free account
- Market cap
- 42.9B
- P/E TTM
- 67.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | FY2026 total revenue raised to $6.6-6.8B; GAAP operating income $1-1.1B; non-GAAP operating income $1.7-1.8B; gross margin high-80% range; other income (expense) $25-50M expense; diluted ADS outstanding ~118M · full year |
| 6 May 26 | Raised | FY26 total revenue raised to $6.3-6.5B from $6.2-6.4B; GAAP operating income raised to $750-850M from $700-800M; Non-GAAP operating income raised to $1.45-1.55B from $1.4-1.5B; GAAP gross margin maintained at high-80% range; GAAP operating expenses maintained at $4.7-4.9B. · full year |
| 26 Feb 26 | Raised | FY2026 total revenue $6.2-6.4B; gross margin high-80% range; other income/expense $25-50M expense; diluted ADS ~118M · full year |
| 6 Nov 25 | Reaffirmed | FY25 revenue guidance $5.1-5.3B; gross margin mid-to-high 80% range; operating expenses expected to deliver meaningful operating leverage. · full year |
| 6 Aug 25 | Raised | FY2025 revenue guidance $5.0B to $5.3B; gross margin expected mid- to high-80% range · full year |
BeOne Medicines Ltd. — questions
- What guidance did BeOne Medicines Ltd. give?
- On 2026-08-05: "FY2026 total revenue raised to $6.6-6.8B; GAAP operating income $1-1.1B; non-GAAP operating income $1.7-1.8B; gross margin high-80% range; other income (expense) $25-50M expense; diluted ADS outstanding ~118M"
- When does BeOne Medicines Ltd. report earnings?
- BeOne Medicines Ltd.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from BeOne Medicines Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.